Marta Stanzani

Treviso, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxis.

Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxis.

Journal: Bone marrow transplantation

Published: April 13, 2025

Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?

Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 11, 2024

Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?

Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?

Journal: Current opinion in infectious diseases

Published: July 11, 2023

Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.

Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.

Journal: Mycoses

Published: May 12, 2022

Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents.

Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents.

Journal: European journal of haematology

Published: October 19, 2021

Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs.

Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs.

Journal: The Lancet. Haematology

Published: April 20, 2021

Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study.

Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study.

Journal: The Journal of infection

Published: February 11, 2021

Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients.

Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients.

Journal: Microorganisms

Published: November 12, 2020

Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in Italy.

Prospective multicentre study on azole resistance in Aspergillus isolates from surveillance cultures in haematological patients in Italy.

Journal: Journal of global antimicrobial resistance

Published: December 11, 2019

Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature.

Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature.

Journal: Mycoses

Published: July 13, 2019

Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease.

Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease.

Journal: Journal of fungi (Basel, Switzerland)

Published: November 16, 2018

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.

Journal: The Journal of infection

Published: September 06, 2018

Showing 1-12 of 37

Last Updated: 09/26/2026